Article
Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Archives of toxicology - 1 Dec 2013
Selinski Silvia, Blaszkewicz Meinolf, Ickstadt Katja, Hengstler Jan G, Golka Klaus
Abstract excerpt
Polymorphisms of N-acetyltransferase 2 (NAT2) are well known to modify urinary bladder cancer risk as well as efficacy and toxicity of pharmaceuticals via reduction in the enzyme's acetylation capacity. Nevertheless, the discussion about optimal NAT2 phenotype prediction, particularly differentiation between different degrees of slow acetylation, is still controversial. Therefore, we investigated the impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
